Prevalence of mutations or translocations of SETD1A have not yet been reported cancer, however, SETD1A is amplified in mixed ductal and lobular and invasive breast carcinomas, suggesting that increased copy number might constitute one of the mechanisms responsible for its overexpression in cancer. This evidence concerns the gene SETD1A and invasive breast carcinoma.